It's funny goodluck http://trannytube.fun tranytube The steep price gains, as well as the floor price that Amgenhas set with its initial $120 per-share offer, deterred severalpharmaceutical and biotechnology companies that would otherwisehave been interested in bidding, people familiar with the mattersaid previously.